• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇对HepG2细胞脂肪变性和线粒体氧化应激的有益作用。

The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.

作者信息

Izdebska Magdalena, Piątkowska-Chmiel Iwona, Korolczuk Agnieszka, Herbet Mariola, Gawrońska-Grzywacz Monika, Gieroba Renata, Sysa Marcin, Czajkowska-Bania Klaudia, Cygal Marcelina, Korga Agnieszka, Dudka Jarosław

机构信息

a Department of Toxicology, Medical University of Lublin, Chodzki 8, Lublin 20-093, Poland.

b Department of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, Lublin 20-090, Poland.

出版信息

Can J Physiol Pharmacol. 2017 Dec;95(12):1442-1453. doi: 10.1139/cjpp-2016-0561. Epub 2017 Jul 31.

DOI:10.1139/cjpp-2016-0561
PMID:28759727
Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently one of the most common chronic liver diseases, especially in developed countries. One group of substances with a potential use in the treatment of NAFLD are plant polyphenols, represented by resveratrol. The aim of this study was to evaluate the effect of resveratrol on steatosis and oxidative stress in HepG2 cells. The steatosis of cells was carried out using free fatty acids: oleic or palmitic acid and their mixtures. Steatosis was visualized using the intracellular lipid staining by Nile Red dye with a fluorescence microscope. This study also determined the viability of cells and mitochondrial membrane potential. The current study showed that fatty acids and their mixtures induced fat overloading in HepG2 cells. In the group of cells incubated with oleic acid (OA), observed changes were moderate with prevailing micro-vesicular steatosis. In case of cells incubated with palmitic acid (PA) and the mixtures of fatty acids, micro- and macro-vacuolar steatosis occurred in most of the cells. Resveratrol decreased steatosis in HepG2 cells induced by OA, PA, as well as their mixtures, and in most of experimental groups did not reduce cells viability. Resveratrol reduced the oxidative stress in HepG2 cells treated with fatty acids mixtures.

摘要

非酒精性脂肪性肝病(NAFLD)是目前最常见的慢性肝病之一,尤其是在发达国家。一类有潜力用于治疗NAFLD的物质是植物多酚,白藜芦醇是其代表。本研究的目的是评估白藜芦醇对HepG2细胞脂肪变性和氧化应激的影响。使用游离脂肪酸:油酸或棕榈酸及其混合物诱导细胞脂肪变性。通过尼罗红染料进行细胞内脂质染色,并用荧光显微镜观察脂肪变性。本研究还测定了细胞活力和线粒体膜电位。当前研究表明,脂肪酸及其混合物会导致HepG2细胞脂肪过载。在用油酸(OA)孵育的细胞组中,观察到的变化较为温和,主要为微泡性脂肪变性。在用棕榈酸(PA)和脂肪酸混合物孵育的细胞中,大多数细胞出现了微泡和大泡性脂肪变性。白藜芦醇可减轻OA、PA及其混合物诱导的HepG2细胞脂肪变性,并且在大多数实验组中不会降低细胞活力。白藜芦醇可减轻用脂肪酸混合物处理的HepG2细胞中的氧化应激。

相似文献

1
The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.白藜芦醇对HepG2细胞脂肪变性和线粒体氧化应激的有益作用。
Can J Physiol Pharmacol. 2017 Dec;95(12):1442-1453. doi: 10.1139/cjpp-2016-0561. Epub 2017 Jul 31.
2
Resveratrol Limits Lipogenesis and Enhance Mitochondrial Activity in HepG2 Cells.白藜芦醇限制HepG2细胞中的脂肪生成并增强线粒体活性。
J Pharm Pharm Sci. 2018;21(1):504-515. doi: 10.18433/jpps29994.
3
In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis.用饱和脂肪酸对HepG2细胞进行体外处理,可重现非酒精性脂肪性肝炎中发现的线粒体功能障碍。
Dis Model Mech. 2015 Feb;8(2):183-91. doi: 10.1242/dmm.018234. Epub 2014 Dec 24.
4
Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.白藜芦醇通过激活 PPARα 通路改善脂代谢和氧化还原平衡,从而防治非酒精性脂肪性肝病。
Appl Physiol Nutr Metab. 2020 Mar;45(3):227-239. doi: 10.1139/apnm-2019-0057. Epub 2019 Jun 7.
5
Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.油酸可保护肝细胞及非酒精性脂肪性肝炎大鼠中饱和脂肪酸介导的脂毒性。
Life Sci. 2018 Jun 15;203:291-304. doi: 10.1016/j.lfs.2018.04.022. Epub 2018 Apr 27.
6
(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease.(+)-硫辛酸可减少非酒精性脂肪性肝病体外模型中线粒体未折叠蛋白反应,减轻氧化应激和衰老。
J Transl Med. 2024 Jan 20;22(1):82. doi: 10.1186/s12967-024-04880-x.
7
Cellular glutathione in fatty liver in vitro models.细胞内谷胱甘肽在体外脂肪性肝病模型中的作用。
Toxicol In Vitro. 2011 Oct;25(7):1501-6. doi: 10.1016/j.tiv.2011.05.011. Epub 2011 May 17.
8
Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.牛磺酸通过抑制非酒精性脂肪性肝病模型体内和体外的氧化应激来减轻肝脂肪变性的发展。
Amino Acids. 2018 Sep;50(9):1279-1288. doi: 10.1007/s00726-018-2605-8. Epub 2018 Jun 26.
9
Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function.膳食多酚通过调节脂代谢和改善线粒体功能来防止非酒精性脂肪性肝病体外模型中油酸诱导的脂肪变性。
Nutrients. 2019 Mar 3;11(3):541. doi: 10.3390/nu11030541.
10
Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1.白藜芦醇通过与关键生物钟调节因子 Bmal1 相关的机制之一维持脂代谢稳态。
Molecules. 2019 Aug 12;24(16):2916. doi: 10.3390/molecules24162916.

引用本文的文献

1
Unraveling the Beneficial Role of Resveratrol in Fructose-Induced Non-Alcoholic Steatohepatitis with a Focus on the AMPK/Nrf2 Signaling Axis.解析白藜芦醇在果糖诱导的非酒精性脂肪性肝炎中的有益作用:聚焦AMPK/Nrf2信号轴
Medicina (Kaunas). 2025 Jan 16;61(1):139. doi: 10.3390/medicina61010139.
2
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?白藜芦醇是否能改善代谢相关脂肪性肝病(MASLD)?
Int J Mol Sci. 2024 Mar 27;25(7):3746. doi: 10.3390/ijms25073746.
3
Korean red ginseng formula attenuates non-alcoholic fatty liver disease in oleic acid-induced HepG2 cells and high-fat diet-induced rats.
韩国红参配方减轻油酸诱导的HepG2细胞和高脂饮食诱导的大鼠中的非酒精性脂肪性肝病。
Heliyon. 2023 Nov 4;9(11):e21846. doi: 10.1016/j.heliyon.2023.e21846. eCollection 2023 Nov.
4
Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs-EBP interaction recover NAFLD through enhancing mitochondrial function in mice.脂联素受体1/2激动剂与内源性大麻素-内源性大麻素结合蛋白相互作用抑制剂对AMPK的协同激活作用通过增强小鼠线粒体功能恢复非酒精性脂肪性肝病。
Acta Pharm Sin B. 2023 Feb;13(2):542-558. doi: 10.1016/j.apsb.2022.10.003. Epub 2022 Oct 14.
5
Nocellara Del Belice ( L. Cultivar): Leaf Extract Concentrated in Phenolic Compounds and Its Anti-Inflammatory and Radical Scavenging Activity.诺切拉·德尔·贝利切(L. 品种):富含酚类化合物的叶提取物及其抗炎和自由基清除活性。
Plants (Basel). 2022 Dec 21;12(1):27. doi: 10.3390/plants12010027.
6
Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.草药和活性成分在中医指导下改善非酒精性脂肪肝。
Front Endocrinol (Lausanne). 2022 Sep 20;13:1000727. doi: 10.3389/fendo.2022.1000727. eCollection 2022.
7
Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中氧化应激诱导衰老的调节
Antioxidants (Basel). 2022 May 16;11(5):975. doi: 10.3390/antiox11050975.
8
A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases.抗氧化剂在非酒精性脂肪性肝病中的作用的分子洞察。
Oxid Med Cell Longev. 2022 May 11;2022:9233650. doi: 10.1155/2022/9233650. eCollection 2022.
9
The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review.纳米医学在非酒精性脂肪性肝病管理中的新兴作用:最新综述
Bioinorg Chem Appl. 2021 Oct 8;2021:4041415. doi: 10.1155/2021/4041415. eCollection 2021.
10
Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.口服维生素C补充剂对非酒精性脂肪性肝病患者肝脏健康及相关参数的影响:一项随机临床试验
Front Nutr. 2021 Sep 14;8:745609. doi: 10.3389/fnut.2021.745609. eCollection 2021.